Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Cancer Treatment and Toxicity (Deadline: 10 March 2026)
- Pharmacogenomics and Pediatric Pharmacotherapy (Deadline: 10 March 2026)
- Pharmacokinetics and Pharmacometrics Driving Innovation (Deadline: 12 March 2026)
- Potential Pharmacotherapeutic Targets in Neurodegenerative Diseases (Deadline: 20 March 2026)
- Novel Therapeutic Targets in the Cardiovascular Treatment Landscape (Deadline: 22 March 2026)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends (Deadline: 25 March 2026)
- Cholinergic Modulation, Anticholinergic Burden, and Neuroprotection: Mechanisms to Therapeutics (Deadline: 25 March 2026)
- Advances in Prostate Cancer Therapeutics (Deadline: 25 March 2026)
- Melatonin Applications in Pharmaceutical Science (Deadline: 25 March 2026)
- Challenges in Discovering Innovations Related to Biofilms: Virulence, Spread, Control Strategies and Treatment (Deadline: 25 March 2026)
- Pharmacotherapy and Molecular Biomarkers of Metabolic Diseases (Deadline: 25 March 2026)
- Kynurenine Pathway: A Novel Therapeutic Opportunity—2nd Edition (Deadline: 25 March 2026)
- Novel Anti-Obesity Pharmacotherapies (Deadline: 25 March 2026)
- Novel Vasoactive and Anti-Inflammatory Agents: From Mechanisms to Therapeutic Applications (Deadline: 25 March 2026)
- Discovery and Validation of Novel Antimicrobial Molecules for the Treatment of Multidrug-Resistant Bacterial Infections (Deadline: 27 March 2026)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy, 2nd Edition (Deadline: 27 March 2026)
- Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds (Deadline: 31 March 2026)
- Advances in Antiparasitic Drug Research (Deadline: 31 March 2026)
- Membrane Receptors in Disease: Mechanisms and Targeted Therapeutic Strategies (Deadline: 31 March 2026)
- Advances in Ophthalmic Drug Discovery and Delivery: From Targets to Treatments (Deadline: 10 April 2026)
- Emerging Therapeutics for the Prevention of Chemotherapy-Induced Cardiotoxicity: Advances and Future Perspectives (Deadline: 20 April 2026)
- Next-Generation Targeted Therapy: vNARs, VHH, and Peptides as Drug Carriers and Intracellular Neutralizing Agents (Deadline: 20 April 2026)
- Recent Advances in Psychopharmacology: 2nd Edition (Deadline: 24 April 2026)
- Targeting Neuromodulators: Effective Therapeutic Strategies for Brain Disorders (Deadline: 24 April 2026)
- New Development in Pharmacotherapy of Kidney Diseases (Deadline: 25 April 2026)
- Pharmacology of Antidepressants: Recent Advances (Deadline: 25 April 2026)
- Potential Therapeutic Targets for the Management of Diabetes Mellitus, Obesity and Cancer (Deadline: 25 April 2026)
- Endocrine Diseases and Pharmacogenomics (Deadline: 25 April 2026)
- Pharmaceutical Approaches to Orofacial Pain and Chronic Pain Conditions (Deadline: 25 April 2026)
- Epithelial Plasticity and Therapy Resistance in Cancer (Deadline: 25 April 2026)
- Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety (Deadline: 25 April 2026)
- Emerging Therapeutic Strategies for Heart Diseases (Deadline: 25 April 2026)
- Pharmaceutical and Biomaterial Approaches for Preventive and Restorative Dentistry (Deadline: 25 April 2026)
- microRNAs and Perioperative Pharmacology (Deadline: 25 April 2026)
- New Perspectives in Ocular Pharmacology: 2nd Edition (Deadline: 26 April 2026)
- Fluoroquinolones, 2nd Edition (Deadline: 27 April 2026)
- Tumor Immunopharmacology, 2nd Edition (Deadline: 27 April 2026)
- Pharmacological Strategies to Modulate Symptoms in Autism Spectrum Disorders (ASD) (Deadline: 30 April 2026)
- Innovative Drug Delivery and Mitochondrial-Targeted Therapies (Deadline: 30 April 2026)
- New Trends in the Treatment of Neuropsychiatric Disorders (Deadline: 30 April 2026)
- Computational Predictions of Molecules with Potential Therapeutic Effects: 2nd Edition (Deadline: 30 April 2026)
- The Therapeutic Potential of Neurotrophin Signaling in Neurodegenerative Disorders (Deadline: 30 April 2026)
- Ophthalmic Drugs and Pharmacology (Deadline: 1 May 2026)
- Novel Drug Compositions for Ischemic Stroke: Mechanisms and Clinical Applications (Deadline: 20 May 2026)
- Pharmacogenomics for Precision Medicine, 2nd Edition (Deadline: 23 May 2026)
- Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine (Deadline: 25 May 2026)
- Innovations in Therapeutic Strategies for Retinal and Neurodegenerative Diseases (Deadline: 25 May 2026)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology—2nd Edition (Deadline: 25 May 2026)
- Pharmacotherapy of Prostate Cancer (Deadline: 25 May 2026)
- Antimicrobial Therapies Affect the Microbial Ecosystems Within Our Body: The Urinary Microbiome and Urolithiasis (Deadline: 25 May 2026)
- Infectious Disease Epidemiology and Pharmaceutical Development in the Era of Antimicrobial Resistance (AMR) (Deadline: 25 May 2026)
- Ischemic Stroke: Current and Emerging Treatment Strategies (Deadline: 25 May 2026)
- Histamine Receptors: Ligand Design, Pharmacology, and Therapeutic Applications (Deadline: 25 May 2026)
- Impact of Drug Transporter Gene Variation on Pharmacokinetics and Clinical Outcomes in Chronic Disease Therapy (Deadline: 25 May 2026)
- Hepatitis B and Delta Virus Infections: Mechanistic Insights and Clinical Drug Therapy (Deadline: 25 May 2026)
- Research Advances in Targeted Therapy for Facial Skin Diseases (Deadline: 25 May 2026)
- Deregulated Signaling Pathways and Innovative Therapeutic Approaches in Cancer (Deadline: 25 May 2026)
- Pharmacotherapy for Alzheimer’s Disease, 2nd Edition (Deadline: 25 May 2026)
- Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances, 2nd Edition (Deadline: 25 May 2026)
- Novel Therapeutic Strategies for Alzheimer’s Disease Treatment (Deadline: 29 May 2026)
- Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy (Deadline: 29 May 2026)
- Exploring Novel Therapies and Drug Efficacy for Inflammatory Bowel Disease (Deadline: 30 May 2026)
- New Insights of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Biomedical Applications (Deadline: 31 May 2026)
- Next-Generation Antibiotic Strategies Against Drug-Resistant Bacteria (Deadline: 31 May 2026)
- Comprehensive Strategies in Cancer Immunotherapy (Deadline: 31 May 2026)
- Applications of Stem Cells and Organoids in Disease Modeling, Drug Discovery and Clinical Evaluation (Deadline: 31 May 2026)
- Pharmaceutical Targeting of Lipids in Metabolic and Neurological Disorders (Deadline: 1 June 2026)
- Immune Modulation and Precision Targeting of the Tumor Microenvironment (Deadline: 22 June 2026)
- Pharmacogenomics and Ethnic Diversity: Optimizing Drug Response Across Populations (Deadline: 25 June 2026)
- Epidemiological Surveillance of Clinical Bacterial Infections and Antimicrobial Resistance Management (Deadline: 25 June 2026)
- Advances in Drug Hypersensitivity Research (Deadline: 25 June 2026)
- New and Emerging Treatment Strategies for Gastrointestinal Diseases, 2nd Edition (Deadline: 25 June 2026)
- Treatment for HPV-Associated Cervical Cancer: Novel Therapeutic Strategies (Deadline: 26 June 2026)
- Use of Anesthetic Agents: Management and New Strategy: 2nd Edition (Deadline: 26 June 2026)
- Pharmaceuticals for Inflammatory Bowel Disease (IBD) (Deadline: 30 June 2026)
- Advances in Smooth Muscle Pharmacology (Deadline: 30 June 2026)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success, 2nd Edition (Deadline: 30 June 2026)
- Novel Drug Candidates for the Treatment of Cardiac and Renal Diseases (Deadline: 30 June 2026)
- Curcumin: Current Status and Future Challenges in Drug Delivery and Advanced Formulations (Deadline: 30 June 2026)
- Ferroptosis in Cancer and Beyond: Mechanisms, Biomarkers, and Interventions (Deadline: 30 June 2026)
- Polysulfide Pharmacology: Biological Effects and Therapeutic Potential in Pain, Inflammation, and CNS Disorders (Deadline: 30 June 2026)
- Drug Development and Emerging Pharmacotherapies in Stroke Management (Deadline: 30 June 2026)
- Pharmacovigilance in Drug Therapy and Adverse Reactions (Deadline: 30 June 2026)
- Cell Death, Mitochondrial Metabolism and Cancer Immunotherapy (Deadline: 30 June 2026)
- Pharmacological Targeting of Immune Checkpoints and Regulatory Pathways (Deadline: 30 June 2026)
- Hormone Signaling in Cardioprotection and Regeneration (Deadline: 30 June 2026)
- Optimizing Immunotherapeutic Strategies for Hematologic Malignancies (Deadline: 30 June 2026)
- Pharmacotherapy of Endometriosis (Deadline: 1 July 2026)
- Recent Advances in Cancer Diagnosis and Therapy (Deadline: 5 July 2026)
- Advances in Antibody–Drug Conjugates (Deadline: 20 July 2026)
- G-Protein-Coupled Receptors as Therapeutic Targets for CNS Disorders (Deadline: 24 July 2026)
- Research Progress and Drug Intervention Strategies for Oral Health-Related Diseases (Deadline: 25 July 2026)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria: 2nd Edition (Deadline: 25 July 2026)
- Clinical Advances in the Neuropharmacological Treatment of Substance Use Disorders: 2nd Edition (Deadline: 25 July 2026)
- Emerging Therapies for Diabetes and Obesity (Deadline: 25 July 2026)
- Pharmacotherapy of Inflammatory Bowel Disease, 2nd Edition (Deadline: 25 July 2026)
- Advances in Perinatal Pharmacology (Deadline: 25 July 2026)
- Therapeutic Drug Monitoring and Adverse Drug Reactions: 3rd Edition (Deadline: 25 July 2026)
- Drug Target Exploration and Drug Design & Development Based on Small Molecule: 2nd Edition (Deadline: 25 July 2026)
- Therapeutic Potential of Cannabinoids and Their Receptors: 2nd Edition (Deadline: 25 July 2026)
- Therapeutic Strategies for Co-Occurring Psychiatric and Substance Use Disorders (Deadline: 25 July 2026)
- Aging-Related Musculoskeletal Disorders: Therapeutic Targets and Pharmacological Strategies (Deadline: 27 July 2026)
- Pharmacological Activities and Therapeutic Potential of Novel Drug Derivatives (Deadline: 31 July 2026)
- Pharmacology and Toxicology of Opioids, 2nd Edition (Deadline: 31 July 2026)
- The Regulatory Roles of the Gut Microbiota in Multisystem Diseases (Deadline: 31 July 2026)
- Advances in Targeted Therapy for Gastrointestinal Cancers (Deadline: 31 July 2026)
- Treating Cognitive Deficits in Neuropsychiatric and Neurodegenerative Disorders: Mechanisms, Targets, and Translational Advances (Deadline: 31 July 2026)
- New Advances and Treatment in Thrombosis and Endothelial Injury Syndromes (Deadline: 31 July 2026)
- Population Pharmacokinetics and Pharmacogenetics, 2nd Edition (Deadline: 10 August 2026)
- Application of Zebrafish Model in Pharmacology and Toxicology (Deadline: 15 August 2026)
- Innovative Approaches to GABAergic Drug Discovery: From Molecular Mechanisms to Advanced Therapeutics (Deadline: 25 August 2026)
- Perioperative Precision in Modern Anesthesia: Efficacy and Safety of Pharmacotherapy with Risk Modulation (Deadline: 25 August 2026)
- Innovative Tools for Drug Analysis and Therapeutic Drug Monitoring (TDM): 2nd Edition (Deadline: 25 August 2026)
- Immunotherapy as a Promising Therapeutic Paradigm for Cancers (Deadline: 25 August 2026)
- Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes (Deadline: 27 August 2026)
- Drug Candidates for the Treatment of Oral Cancer and Oral Cancer Pain, 2nd Edition (Deadline: 27 August 2026)
- Vitamin D and Its Derivatives in Pharmacology: Mechanisms and Therapeutic Applications (Deadline: 27 August 2026)
- Applications of Pharmacogenomics in Precision Medicine (Deadline: 31 August 2026)
- Contemporary Challenges and Solutions in Antimicrobial Use (Deadline: 31 August 2026)
- Advances in Neuropharmacology and Brain Injury Therapeutics (Deadline: 31 August 2026)
- Active Molecule Design Based on Conformational Pharmacology: Synthesis, NMR Spectroscopy, and Computational Modeling (Deadline: 31 August 2026)
- From Prion Molecular Mechanisms to Targeted Therapeutics: Informing the Broader Proteinopathy Paradigm (Deadline: 31 August 2026)
- Advances in Drug Treatment of Systemic Amyloidosis (Deadline: 31 August 2026)
- Low-Dose Naltrexone for Chronic and Cancer Pain (Deadline: 25 September 2026)
- Targeting Epigenetic Regulation for Cancer Therapy (Deadline: 30 September 2026)
- Pain Management: Novel Biomarkers and Therapeutic Targets (Deadline: 30 September 2026)
- Pharmacological Therapies and Biomarkers for Diseases in Correlation with Age Groups of Patients (Deadline: 30 September 2026)
- Novel Neuroprotective Agents and Therapeutics (Deadline: 30 September 2026)
- New Advances in Antiarrhythmic Drugs (Deadline: 20 October 2026)
- Pharmacotherapy of Thromboembolism (Deadline: 25 October 2026)
- NeuroImmunoEndocrinology (Deadline: 31 October 2026)
- Molecular Insights and Clinical Implications in Geriatric Medicine and Drug Development (Deadline: 31 October 2026)
- Novel Cannabinoid Receptor Ligands: Discovery, Pharmacology, and Therapeutic Applications (Deadline: 31 October 2026)
- Drug Safety and Risk Management in Clinical Practice: 2nd Edition (Deadline: 31 October 2026)
- Pharmacotherapy of Macular Diseases (Deadline: 31 December 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
